Extended interval dosing of natalizumab: More evidence in support

被引：1
|
作者：
Toljan, Karlo [1 ]
Conway, Devon S. [1 ]
机构：
[1] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, 9500 Euclid Ave U10, Cleveland, OH 44195 USA
来源：
NEUROTHERAPEUTICS | 2024年 / 21卷 / 03期
关键词：
Multiple sclerosis; Disease-modifying therapy; Natalizumab; Extended interval dosing;
D O I：
10.1016/j.neurot.2024.e00351
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Real world effectiveness of Natalizumab extended interval dosing in a French cohort
    Pelle, J.
    Briant, A.
    Lebrun-Frenay, C.
    Cohen, M.
    Mondot, L.
    De Seze, J.
    Bigaut, K.
    Collongues, N.
    Kremer, L.
    Ricard, D.
    Bompaire, F.
    Sallansonnet-Froment, M.
    Ohlmann, C.
    Ciron, J.
    Biotti, D.
    Pignolet, B.
    Parienti, J.
    Defer, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 207 - 207
  • [32] Modelling efficacy of natalizumab in patients who switch from standard interval dosing (SID) to extended interval dosing (EID)
    Chang, I.
    Muralidharan, K.
    Campbell, N.
    Ho, P. -R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 480 - 480
  • [33] Extended interval dosing of natalizumab shows comparable efficacy to standard interval dosing starting from the second year of treatment
    Ruggieri, S.
    Ianniello, A.
    De Giglio, L.
    Altieri, M.
    Centonze, D.
    Cortese, A.
    Fantozzi, R.
    Galgani, S.
    Gasperini, C.
    Landi, D.
    Marfia, G. A.
    Mirabella, M.
    Nistri, R.
    Nociti, V.
    Romano, S.
    Salvetti, M.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1009 - 1010
  • [34] No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS
    Ryerson, Lana Zhovtis
    Naismith, Robert T.
    Krupp, Lauren B.
    Charvet, Leigh E.
    Liao, Shirley
    Fisher, Elizabeth
    de Moor, Carl
    Williams, James R.
    Campbell, Nolan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [35] Natalizumab extended interval dosing: what about wearing-off effect?
    Bernardes, Catarina
    Fernandes, Catarina
    Cunha, Carolina
    Batista, Sonia
    Nunes, Carla
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1010 - 1011
  • [36] Natalizumab extended interval dosing: what about wearing-off effect?
    Bernardes, Catarina
    Fernandes, Catarina
    Cunha, Carolina
    Nunes, Carla
    Macario, Carmo
    Sousa, Livia
    Batista, Sonia
    Correia, Ines
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 458
  • [37] Progressive Multifocal Leukoencephalopathy with Natalizumab Extended or Standard Interval Dosing in US and ROW
    Dsilva, L.
    McCarthy, K.
    Lyons, J.
    Cabigas, B.
    Campbell, N.
    Kong, G.
    Chin, W.
    Adams, B.
    Kuhelj, R.
    Singhal, P.
    Smirnakis, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 459 - 459
  • [38] MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study
    De Mercanti, Stefania Federica
    Signori, Alessio
    Cordioli, Cinzia
    Signoriello, Elisabetta
    Lus, Giacomo
    Bonavita, Simona
    Abbadessa, Gianmarco
    Lavorgna, Luigi
    Maniscalco, Giorgia Teresa
    Curti, Erica
    Lorefice, Lorena
    Cocco, Eleonora
    Nociti, Viviana
    Mirabella, Massimiliano
    Baroncini, Damiano
    Mataluni, Giorgia
    Landi, Doriana
    Petruzzo, Martina
    Lanzillo, Roberta
    Gandoglia, Ilaria
    Laroni, Alice
    Frangiamore, Rita
    Sartori, Arianna
    Cavalla, Paola
    Costantini, Gianfranco
    Capra, Ruggero
    Sormani, Maria Pia
    Clerico, Marinella
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 424
  • [39] Long-term effectiveness of extended interval dosing of natalizumab in multiple sclerosis
    Ryerson, L. Zhovtis
    Lee, S.
    Bacon, T.
    Toth, E.
    Chinea, R.
    Gragui, D.
    Kister, I.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 358 - 359
  • [40] Influence of personalized extended interval dosing on the natalizumab wearing-off effect
    Toorop, Alyssa
    Wessels, Mark
    Gelissen, Liza
    Hoitsma, E.
    Zeinstra, Esther
    van Rooij, Luuk
    van Munster, Caspar
    Vennegoor, Anke
    Mostert, Jop
    Wokke, Beatrijs
    Kalkers, Nynke. F.
    Hoogervorst, E. L. J.
    van Eijk, Jeroen
    Roosendaal, Christiaan
    Kragt, Jolijn
    Eurelings, Marijke
    van Genugten, Jessie
    Nielsen, Jessica
    Sinnige, Okke
    Kloosterziel, Mark
    Arnoldus, Edo P. J.
    van Dijk, Gert
    Bouvy, Willem
    Strijbis, Eva
    van Oosten, Bob
    Brigit, de Jong
    Lissenberg-Witte, Birgit
    Rispens, Theo
    Uitdehaag, Bernard
    Killestein, Joep
    van Kempen, Zoe
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 387 - 388
12345